Class / Patent application number | Description | Number of patent applications / Date published |
514642000 | Quaternary ammonium containing | 63 |
20090143476 | Antimicrobial Nanoemulsion Compositions and Methods - The present invention relates to compositions and methods for decreasing the infectivity, morbidity, and rate of mortality associated with a variety of pathogenic organisms and viruses. The present invention also relates to methods and compositions for decontaminating areas colonized or otherwise infected by pathogenic organisms and viruses. Moreover, the present invention relates to methods and compositions for decreasing the infectivity of pathogenic organisms in foodstuffs. | 06-04-2009 |
20090143477 | Antimicrobial Nanoemulsion Compositions and Methods - The present invention relates to compositions and methods for decreasing the infectivity, morbidity, and rate of mortality associated with a variety of pathogenic organisms and viruses. The present invention also relates to methods and compositions for decontaminating areas colonized or otherwise infected by pathogenic organisms and viruses. Moreover, the present invention relates to methods and compositions for decreasing the infectivity of pathogenic organisms in foodstuffs. | 06-04-2009 |
20090149547 | VIRUCIDAL DISINFECTANT FOR AVIAN INFLUENZA VIRUS - A novel virucidal disinfectant for avian influenza virus is provided. A virucidal disinfectant for avian influenza virus characterized by containing as essential constituents
| 06-11-2009 |
20090176887 | Biocidal Compositions and Methods - Biocidal compositions comprises an effective amount of a biocidal agent such as a quaternary ammonium compound or a blend of quaternary ammonium compounds and an effective amount of a cellular membrane disruptor. The synergy index of the biocidal agent and the cellular membrane disruptor is less than 1. The biocidal compositions can further comprise an effective amount of a chemical stabilizer and other optional components such as a nonionic surfactant. Methods for making and utilizing such biocidal compositions are also disclosed. | 07-09-2009 |
20090203795 | POLYQUATERNIUM-1 SYNTHESIS METHODS AND ASSOCIATED FORMULATIONS - A multipurpose solution for contact lens care, comprising: an aqueous liquid medium; a quaternary ammonium polymer having an average molecular weight as determined by the proton NMR method of at least | 08-13-2009 |
20090253800 | INTERACTION CONTROL OF CATIONIC BIOCIDES USING LABILE ANIONIC POLYELECTROLYTES - Methods of inhibiting the uptake of cationic biocides into medical devices such as contact lenses and implants are described. Methods of stabilizing emulsions containing cationic biocides are also described. In particular, the present invention provides for the use of polymers acting as labile anionic polyelectrolytes to reversibly bind cationic biocides. The reversible binding can reduce the deleterious effects of cationic biocides while maintaining biocidal activity. Preferred polymers include galactomannan and polyvinyl alcohol. | 10-08-2009 |
20100179226 | Topical Dosage Form Comprising Tri-Substituted Glycerol Compounds - The present invention relates to pharmaceutical dosage forms for topical administration comprising a tri-substituted glycerol compound or a pharmaceutically acceptable salt thereof. The invention also relates to a corresponding method for preparing such dosage forms as well as to their use as medicaments for the treatment of cancer and immune diseases. | 07-15-2010 |
20100227930 | ECOLOGICAL QUATERNARY AMMONIUM DISINFECTANT CLEANER - The present invention concerns an ecological benzineless quaternary ammonium disinfectant cleaner comprising quaternary ammonium compound(s) either (i) including octyl decyl dimethyl ammonium chloride, dioctyl dimethyl ammonium chloride and didecyl dimethyl ammonium chloride, in a relative proportion of about 2:1:1 by weight, or (ii) consisting essentially of quaternary ammonium compounds consisting essentially of didecyl dimethyl ammonium chloride; the disinfectant cleaner also comprising a sequesterant such as polycarboxylates and diamines and combinations thereof; a surfactant; a builder such as silicates, carbonates and citrates and combinations thereof; and preferably a solvent such as glycol ether series. This disinfectant cleaner enables improved properties regarding ASTM D4488-95-A5, mammalian acute toxicity orally and dermally; aquatic acute toxicity for Daphnia Magna; higher water hardness tolerance; improved adherence to vertical and horizontal surfaces and it meets the stringent requirements of the Ecologo™ CCD-166 certification. | 09-09-2010 |
20100227931 | ANTIFUNGAL COMPOSITION - The present invention provides the antifungal composition, containing the compound (a) selected from specific quaternary ammonium salts and specific amine oxides and the sequestering agent (b) having a calcium-chelating constant of 4 to 12 at a mass ratio (a)/(b) of 0.01 to 10. | 09-09-2010 |
20100273888 | POLYQUATERNIUM-1 SYNTHESIS METHODS AND ASSOCIATED FORMULATIONS - A multipurpose solution for contact lens care, comprising: an aqueous liquid medium; a quaternary ammonium polymer having an average molecular weight as determined by the proton NMR method of at least 28 k, and methods for making the same. | 10-28-2010 |
20100292339 | Genetic Polymorphisms Predictive of Nutritional Requirements for Choline in Subjects - Methods of predicting susceptibility of a subject to develop one or more choline deficiency-associated health effects are provided, comprising determining a genotype of the subject with respect to at least one choline metabolism gene and comparing the genotype of the subject with at least one reference genotype associated with susceptibility to develop the one or more choline deficiency-associated health effects. | 11-18-2010 |
20110009493 | Broad Spectrum Disinfecting and Sterilizing Composition - The present invention relates to antimicrobial compositions including an aromatic dialdehyde and a quaternary ammonium compound wherein the aromatic dialdehyde is orthophthalaldehyde, isophthalaldehyde, terephthalaldehyde, or combinations thereof; the quaternary ammonium compound is didecyldimethylammonium bicarbonate, didecyldimethylammonium carbonate, or didecyldimethylammonium bicarbonate/carbonate; and the ratio of aromatic dialdehyde to quaternary ammonium compound is from about 1:1.2 to about 1:2. The invention also relates to methods of treating surfaces using the antimicrobial compositions of the invention. | 01-13-2011 |
20110028563 | ANTI-MICROBIAL COMPOSITION - The present invention relates to an anti-microbial composition and method of use thereof. In particular, the present invention relates to an anti microbial composition comprising farnesol and cetrimide. | 02-03-2011 |
20110060052 | Biocidal aldehyde composition for oil and gas extraction - A novel combination of a biocide (Glutaraldehyde or OPA), a surfactant, alcohol, and functional excipients for the oil and gas recovery industry. The surfactant is preferably a dual chain quaternary ammonium compound consisting of a mixture of alkyl dimethy-benzylammonium chlorides and alkyl dimethylethylbenzylammonium, that absorbs onto a surface and alters the free energy of that surface. The alcohol is preferably isopropyl alcohol. The functional excipients for the oil and gas recovery industry are a cellulose type proppant, a poloxamer wetting agent, a friction-reducing pluronic block copolymer, a drag reducing agent such as polethylene oxide, and a flocculating agent. The biocide may be OPA of the dialdehyde C | 03-10-2011 |
20110065802 | Chelator Stabilized Cationic Ammonium Compounds and Compositions Comprising the Same - Stabilized cationic ammonium compounds are described. The compounds are stabilized with pyridine-based chelators and/or heteroketo-based chelators that impede the generation of nitrogen comprising groups from the cationic ammonium compounds. | 03-17-2011 |
20110124738 | CHROMATE-FREE CORROSION PROTECTION FOR FUEL TANKS - The present invention relates to a chromate-free composition, to the use thereof for corrosion protection, and to a corrosion protection coating for the inside surfaces of fuel tanks, wherein the composition comprises binding agents, hardening agents, corrosion inhibitors and quaternary ammonium compounds in a quantity of at least 0.1% by weight. | 05-26-2011 |
20110136912 | OPHTHALMIC EMULSION - The present invention is directed to an ophthalmic emulsion. The emulsion has a unique combination of ingredients that promotes the stability of small oil droplets within the emulsion. The emulsion also includes a mucoadhesive polymer that aid in delivering a lipid to the ocular surface. | 06-09-2011 |
20110166236 | CLEANING COMPOSITION - A cleaning and disinfecting composition comprises a long-chain alkyl polyamine, such as dodecyl dipropylene triamine; a long-chain quaternary ammonium salt, such as N,N-didecyl-N,N-dimethylammonium chloride; and a metal carbonate salt, such as potassium carbonate, all in aqueous solution. A sequestering agent, a long-chain alkyl polyethoxylate, an alkanolamine and an anti-corrosive agent may also be present. The composition has a pH of at least 11 when diluted to an in-use concentration, and may be used to clean and disinfect hard surfaces, such as medical, dental and surgical implements, walls, floors, sinks and hard furnishing surfaces, or soft surfaces such as bedding, upholstery or clothing. The composition is effective as a virucide, a sporicide, a bacteriocide, a fungicide, and against yeasts and moulds, without harming the substrate cleansed. | 07-07-2011 |
20110245348 | Method of treating type I diabetes - The method of treating type I diabetes includes the treatment of diabetic patients with choline in order to control the patient's lipid profile. The treatment method includes the step of administering to the patient a therapeutically effective dosage of choline or a pharmaceutically acceptable salt thereof. In human patients, the effective dosage of choline is preferably approximately 10 mg., delivered daily. Although the choline may be injected in solution, it is preferably delivered orally to the patient. | 10-06-2011 |
20120077880 | Highly Concentrated, Spherical Biopolymer Gel Particle Suspensions Prepared by HIPE-Gelation Process - The invention relates to highly concentrated, spherical, biopolymer gel particle suspensions comprising particle of defined particle diameter range (e.g., 1 to 50μ) and process for preparing the suspensions utilizing high internal phase emulsion as intermediate. | 03-29-2012 |
20120077881 | HIPE-Gelation Process for Making Highly Concentrated, Spherical Biopolymer Gel Particle Suspensions - The invention relates to process for making highly concentrated, spherical biopolymer gel particle suspensions comprising particles of defined particle diameter (e.g., range of 1 to 50μ) utilizing high internal phase emulsion as an intermediate. | 03-29-2012 |
20120225948 | Broad spectrum disinfectant - A broad spectrum disinfectant includes a quaternary ammonium halogen, an alkaline agent, a chelating agent, a nonionic surfactant coupler, at least one alkoxylated nonionic surfactant, and water or any aliphatic alcohol. The disinfectant composition is phenol-free, is effective in eradicating microorganisms such as various fungi, and is stable to gamma-irradiation. | 09-06-2012 |
20120295983 | Stabilized Cationic Ammonium Compounds for Topical Compositions - Stabilized cationic ammonium compounds are described. The compounds are stabilized with metal chelators that impede the generation of nitrogen comprising groups from the cationic ammonium compounds. | 11-22-2012 |
20130165525 | METHODS OF MAKING AND USING PRECURSOR POLYELECTROLYTE COMPLEXES - The invention relates to compositions and methods of treatment employing compositions comprising polyelectrolyte complexes. The compositions include a water-soluble first polyelectrolyte bearing a net cationic charge or capable of developing a net cationic charge and a water-soluble second polyelectrolyte bearing a net anionic charge or capable of developing a net anionic charge. The total polyelectrolyte concentration of the first solution is at least 110 millimolar. The composition is free of coacervates, precipitates, latex particles, synthetic block copolymers, silicone copolymers, cross-linked poly(acrylic) and cross-linked water-soluble polyelectrolyte. The composition may be a concentrate, to be diluted prior to use to treat a surface. | 06-27-2013 |
20130237606 | OPHTHALMIC AND CONTACT LENS SOLUTIONS USING CHOLINE - The present invention relates to a lens care solution having 0.001 to about 5 weight percent of a low molecular weight amine of the general formula: | 09-12-2013 |
20140121281 | CATIONIC MICELLES WITH ANIONIC POLYMERIC COUNTERIONS METHODS THEREOF - The invention relates to polymer-micelle complex. The polymer-micelle complexes include a positively charged micelle selected from the group consisting of a monomeric quaternary ammonium compound, a monomeric biguanide compound, and mixtures thereof. The positively charged micelle is electrostatically bound to a water-soluble polymer bearing a negative charge. The polymer does not comprise block copolymer, latex particles, polymer nanoparticles, cross-linked polymers, silicone copolymer, fluorosurfactant, or amphoteric copolymer. The compositions do not form a coacervate, and do not form a film when applied to a surface. | 05-01-2014 |
20140163113 | OPHTHALMIC AND CONTACT LENS SOLUTIONS USING CHOLINE - The present invention relates to a lens care solution having 0.001 to about 5 weight percent of a low molecular weight amine of the general formula: | 06-12-2014 |
20140221495 | ELECTROSPUN POLYMER NANOFIBERS WITH SURFACE ACTIVE QUATERNARY AMMONIUM SALT ANTIMICROBIALS - A fiber having a polymeric matrix and a quarternary ammonium salt. The quarternary ammonium salt contains at least one aliphatic group and no aromatic groups, is not covalently incorporated into the polymeric matrix, and is present on both the surface and in the interior of the fiber. The fiber may be made by electrospinning a solution of the polymer and the quarternary ammonium salt. | 08-07-2014 |
20140343157 | QUAT CLEANER WITH GLYCERIN ETHER ETHOXYLATES - The present invention relates to sanitizing compositions containing glycerin ether ethoxylate solfactant compounds and cationic active antimicrobial agents containing quaternary ammonium groups. Beneficially the compositions provide sanitizing efficacy without diminished performance requiring either increased concentrations of sanitizing agent and/or increased contact time for surfaces treated with the compositions. The compositions are suitable for use as antimicrobials and/or sanitizing agents in various formulations and methods of employing the same. | 11-20-2014 |
20140357723 | Tricholine Nasal Formulation and Method of Use - A commercially-suitable tricholine nasal formulation for administration to a human as a nasal spray is disclosed. The tricholine nasal formulation includes an aqueous solution of tricholine citrate, a volatile oil and a buffer system. The disclosed tricholine nasal formulation possesses an acceptable odor and a reasonable shelf-life. The tricholine nasal formulation may be used to treat the symptoms associated with stress, anxiety, depression, malaise, or “burn out” syndrome. Optionally, a moisturizer is included in the composition to alleviate any dryness resulting from administration of the formulation to a user. A preservative may be included in the composition to produce a longer shelf-life. | 12-04-2014 |
20150065579 | POLYCATIONIC POLYHYDROXYL COMPOUNDS - Described are novel polycationic polyhydroxyl compounds and their uses in personal care compositions. | 03-05-2015 |
20150094376 | Hexamethonium Reverses the Lethal Cardiopulmonary Damages in a Rat Model of Brain Stem Lesions Mimicking Fatal Enterovirus 71 Encephalitis - Disclosed is a method for inhibiting the excessive release of catecholamines of mammals infected by the enterovirus 71 (EV71), and more specially, a method for reversing the cardiopulmonary damages caused from EV71 infection in an animal model by using hexamethoniums. An early administration of a suitable amount of hexamethonium to the rats mimicking enterovirus 71 infection will attenuate the acute excessive release of catecholamines in the body of each rat. Thus, cardiac dysfunction and pulmonary edema generally caused by EV71 encephalitis is prevented and the survival rate of the rats increases. | 04-02-2015 |
20160128325 | OPHTHALMIC AND CONTACT LENS SOLUTIONS USING CHOLINE - The present invention relates to a lens care solution having 0.001 to about 5 weight percent of a low molecular weight amine of the general formula: | 05-12-2016 |
20160150778 | PLASTIC HAVING A BIOCIDAL SURFACE AND METHOD FOR PRODUCING SAID PLASTIC | 06-02-2016 |
514643000 | Benzene ring containing | 29 |
20080255242 | HCI POLYMORPHS OF 3-((2-(DIMETHYLAMINO)METHYL(CYCLOHEX-1-YL)) PHENOL - A crystalline salt of 3-[2-(dimethylamino)methyl(cyclohex-1-yl)] phenol and hydrogen chloride, preferably in a 1:1 composition, including various crystalline forms of this salt, processes for preparing the various crystalline forms of this salt, pharmaceutical compositions containing the various crystalline forms of this salt, and the use of this salt as a pharmacologically active agent in a pharmaceutical composition to treat or inhibit pain or other disorders or disease states. | 10-16-2008 |
20080269345 | Quarternary Ammonium Compound, Process for Producing the Same, Therapeutic Agent for Cerebrovascular Disorder, and Therapeutic Agent for Heart Disease - A quaternary ammonium compound of the present invention is a quaternary ammonium compound represented by general formula (I) or (I′) | 10-30-2008 |
20100216890 | Disinfectant - Disinfectant compositions, containing (a) at least one amine and/or quaternary salt of the general formula (Ia) or (Ib), respectively, and (b) at least one alkanolamine of the general formula (II), or a corresponding salt. The mass ratio of the components in the formulas (I):(II) is between 20:1 and 1:20. The compositions are characterized by an excellent bactericidal and in particular fungicidal action even in small application concentrations and are suitable for use as both disinfectants and preservative agents. | 08-26-2010 |
20110034561 | ANTIBACTERIAL COSMETIC APPLICATOR - Provided is an antibacterial brush material for make-up with long-lasting antibacterial properties, wherein the loss of the antibacterial agent through washing or the like is prevented by treating a synthetic fiber with a phenol compound and one or more quarternary ammonium salts selected from among: alkyl ammonium salts, alkyl benzyl ammonium salts, and alkyl pyridinium salts. Further provided is an antibacterial make-up applicator that uses the brush material. | 02-10-2011 |
20110039941 | USE OF A COMPOSITION FOR TREATING THE SURFACES OF LIVESTOCK BUILDINGS AND/OR THE MATERIAL THEREIN - The invention relates to the use of a composition for treating the surfaces of livestock buildings and/or the material therein in order to eliminate and/or inhibit pathogenic protozoa, and in particular coccidiosis oocysts. According to the invention, said composition essentially comprises the combination of an alkylamine and of a quaternary ammonium or of a quaternary ammonium derivative. | 02-17-2011 |
20110046230 | Salt of Dimethylaminomethyl-Phenyl-Cyclohexane and Crystalline Forms Thereof - Novel 3-[2-(dimethylamino)methyl-(cyclohex-1-yl)]-phenol maleate compounds corresponding to formula I | 02-24-2011 |
20110152378 | DISINFECTANT FORMULATIONS SUITABLE FOR USE AT LOW TEMPERATURE - There is provided a disinfectant composition comprising
| 06-23-2011 |
20110201689 | COMPOSITIONS CONTAINING QUATERNARY AMMONIUM COMPOUNDS - Composition containing quaternary ammonium compounds in which the nitrogen atom is substituted by at least one alkyl group having at least 12 carbon atoms, the composition including at least 20% in weight by weight of the total composition, of ammonium halides in which the nitrogen atom is substituted by at least one alkyl group having at least 14 carbon atoms and more than 5%, preferably more than 7% in weight by weight of the total composition, of ammonium halides in which the nitrogen atom is substituted by at least one alkyl group having at least carbon atoms. Ophthalmic oil-in-water emulsions containing such compositions, the ophthalmic emulsions being useful for eye care or for the treatment of eye conditions are also disclosed. | 08-18-2011 |
20110313049 | ANTIBACTERIAL COMPOSITIONS COMPRISING QUATERNARY AMMONIUM GERMICIDES AND ALKAMINE OXIDES HAVING REDUCED IRRITATION POTENTIAL - Antibacterial compositions having antibacterial effectiveness and reduced eye irritation potential are disclosed. The antibacterial compositions contain a quaternary ammonium compound, an alkamine oxide, a nonionic compound, optional adjuvant materials known in the art, and water. The eye irritation is decreased by decreasing the amount, by weight, of alkamine oxide present in the composition and alternatively, or in combination therewith, increasing the ratio of nonionic material to alkamine oxide present in the composition. | 12-22-2011 |
20120077882 | ANTIBACTERIAL AGENT-COMPRISING POWDERS AND METHODS FOR MANUFACTURING THE SAME - Skin and surface sanitizers and methods for forming skin and surface sanitizers are provided. In one embodiment, a surface sanitizer is formed of a plurality of dry particles. Each dry particle comprises a liquid comprising an antibacterial agent and a dry particulates coating surrounding the liquid. The liquid is present in an amount of from about 10 to about 90 wt. % of each dry particle. The surface sanitizer has a germ kill effectiveness of at least 50%. | 03-29-2012 |
20120295984 | ANTIBACTERIAL COSMETIC APPLICATOR - Antibacterial cosmetic brush hairs include synthetic fibers treated with quaternary ammonium salt, phenolic compound, and acid. The antibacterial cosmetic brush hairs inhibit the loss of the antibacterial effect through washing or the like. | 11-22-2012 |
20130035396 | ANTIMICROBIAL CLEANSING COMPOSITIONS - Antimicrobial cleansing compositions are disclosed. The cleansing compositions include thin liquid/foaming compositions and gels. The antimicrobial cleansing compositions are effective antimicrobials and safe for everyday use. | 02-07-2013 |
20130116331 | MEDICAL GEL - This application pertains to antimicrobial medical gel compositions, the compositions comprising: (a) a gelling agent comprising etherified hydroxyethylcellulose; (b) an antimicrobial agent, specifically the quaternary ammonium compound benzalkonium chloride; (c) a solvent, propanediol being preferred; and (d) water. The compositions through their antimicrobial effectiveness address the problem of cross-contamination leading to infection, while meeting the criteria imposed upon medical gels used in ultrasound procedures which criteria include non-reflectiveness and non-refractiveness to ultrasound waves, pseudoplasticity, spreadability, adherence, acidity compatible with skin, minimal aeration, clarity, and resistance to drying. The medical gels function both as a lubricant and a couplant between a transducer and the skin, and find use in dermal ultrasound, physiotherapy, and medical aesthetic procedures. | 05-09-2013 |
20130210923 | Antimicrobial Hand Soap Composition - Topical aqueous liquid compositions for application to the epidermis which provide a germicidal benefit thereto comprising: 0.02-10% wt. of a germicidally effective amount of a quaternary ammonium surfactant compound, 0.1-25% wt. of at least one anionic surfactant constituent which excludes anionic surfactants of the sulfate and sulfonate types, 0.1-15% wt. of a cationic conditioner constituent, 0-10% wt. of a foam stabilizer constituent; at least 70% wt. of water, and optionally one or more of optional constituents which may be used to impart an aesthetic benefit, e.g., color, fragrance, or a further technical benefit, e.g., viscosity adjustment, to the liquid compositions, characterized in that: (a) the weight ratio of the germicidally effective quaternary ammonium and cationic conditioner constituent to the anionic surfactant constituent is not less than 0.6; and/or, (b) the weight ratio of the germicidally effective quaternary ammonium surfactant compound to the cationic conditioner constituent is less than 0.14; and/or, (c) the ratio of the cationic conditioner constituent to the anionic surfactant constituent is at least 0.5; and, (d) the pH of the liquid composition is between about 3.5 and about 7.5. | 08-15-2013 |
20140100288 | Foaming Topical Antimicrobial Cleaning Compositions - Provided are largely aqueous topical antimicrobial cleaning composition which provides an antimicrobial benefit, as well as methods for their production and methods for their use. The compositions comprise at least two different cationic surfactants which provide a primary antimicrobial benefit, and as a predominant further surfactant an amine oxide surfactant. The composition are at an acidic pH and are highly effective in providing an antimicrobial benefit to topical surfaces, e.g, epidermis and hair. | 04-10-2014 |
20140163114 | TRANS-CLOMIPHENE METABOLITES AND USES THEREOF - The present invention relates to substantially pure metabolites of irara-clomiphene. The invention is also directed to pharmaceutical compositions comprising these metabolites and their use in treating disorders including secondary hypogonadism, type 2 diabetes, elevated cholesterol, elevated triglycerides, wasting, lipodystrophy, female and male infertility, benign prostate hypertrophy, prostate cancer, breast cancer, ovarian cancer and endometrial cancer. | 06-12-2014 |
20140171513 | FOAMING SANITIZING FORMULATIONS AND PRODUCTS INCLUDING A QUATERNARY AMMONIUM COMPOUND - Foaming formulations including a quaternary ammonium compound and a foam stabilizer are disclosed. These foaming formulations are useful as leave-on liquid hand and surface sanitizers. The foaming formulations provide improved aesthetic properties and foaming appearance, while maintaining high antimicrobial capacity. | 06-19-2014 |
20140343158 | COMPOSITIONS FOR TOPICAL TREATMENT - A stable, self-preserving, antimicrobial, composition suitable for the treatment of a variety of dermal as well as subcutaneous conditions. The compositions include as an active ingredient a quaternary ammonium compound, preferably benzethonium chloride, potentiated and synergized with menthyl lactate cooling agent in a cationic carrier. Optionally, a phenoxyethanol preservative and chlorhexidine digluconate antibacterial agent may be used to assist in enhancing the activity. The compositions kill a broad spectrum of gram-negative and gram-positive bacteria, fungus and yeasts. The compositions are used as first aid skin treatments and as skin sanitizers to help prevent bacterial contamination of minor cuts, scrapes and burns. The compositions are particularly useful when applied to the skin after hair removal in that they additionally cool, soothe and moisturize the skin. The compositions may also serve as a base vehicle in which additional skin care ingredients may be added to provide additional functionality to the compositions. | 11-20-2014 |
20140378550 | ANTIMICROBIAL CLEANSER - Compositions containing a quaternary ammonium compound (QAC) “active” to provide an antimicrobial property, a quaternized phospholipid which provides a reduction in potential irritancy of other ingredients as well as foaming and cleansing properties, a second non-ionic or amphoteric surfactant (such as an alkyl amine oxide or linear alkyl polyglucoside) to provide increased foam volume and cleansing properties, a non-ionic or quaternized polymer (such as hydroxypropylmethylcellulose or hydroxypropyl guar hydroxypropyl trimonium chloride) which can provide thickening, foam structure and improved after-feel properties are described. | 12-25-2014 |
20150025153 | Small Molecule CMKLR1 Antagonists in Demyelinating Disease - Compounds and methods are provided for decreasing demyelinating inflammatory disease in a subject by inhibiting the activity of chemokine-like receptor 1 (CMKLR1). In some embodiments such methods include treating demyelinating inflammatory disease in a subject by administering an agent that antagonizes the activity of chemokine-like receptor 1 (CMKLR1) and/or a CMKLR1 ligand (e.g., chemerin or other endogenous CMKLR1 ligands). Candidate compounds include, without limitation, analogs and variants of 2-(alpha-naphthoyl)ethyltrimethylammonium iodide. | 01-22-2015 |
20150045443 | USING AN UNSUBSTITUTED QUATENARY AMMONIUM SALT COMPOSITION WITH OTHER INGREDIENTS AS A SKIN SANITIZING SOLUTION AND NATURAL SKIN CONDITIONER - A water based, alcohol-free, skin sanitizing solution with a natural skin softener, where the nature of the biocidal enhancer used in the process of making the solution significantly increases efficacy while simultaneously enabling much more economical manufacturing, processing and transportation of the product. Because it is water based, no further moisturizing additives are required, and those with sensitive skin, diabetes, allergies or religious beliefs are able to use the product without concern. | 02-12-2015 |
20150148425 | ANTIMICROBIAL COMPOSITION EXHIBITING INCREASED EFFICACY - Materials and apparatus are provided that exhibit increased efficacy. An antimicrobial composition includes a cationic active ingredient disposed within the antimicrobial composition. Further, the antimicrobial composition includes a lauramine oxide surfactant, the lauramine oxide surfactant comprising 0.9 to 1.9 weight percent of the antimicrobial composition. Further, the antimicrobial composition includes a number of co-surfactants, the co-surfactant comprising cocamidopropyl betaine, sunfloweramidopropyl ethonium sulfate, PEG-120 methyl glucose dioleate, lauryl/myristyl amidopropyl amine oxide, lauramidopropylamine oxide, or combinations thereof. Still further, the antimicrobial composition includes a thickener, the thickener comprising hydromethylcellulose, PEG-120 methyl glucose, cocamide MEA, hydroxypropyl methylcellulose or combinations thereof. | 05-28-2015 |
20160000733 | NMDA RECEPTOR ANTAGONIST FORMULATION WITH REDUCED NEUROTOXICITY - The present invention is directed to pharmaceutical compositions of effective amounts of NMDA receptor antagonists and preservative for the administration to a patient in need of effective analgesia and anesthesia. The compositions of the invention advantageously do not cause any significant neurotoxicity. The preferred NMDA receptor antagonist is ketamine. The preferred preservative is benzalkonium chloride. | 01-07-2016 |
20160030315 | ANTIMICROBIAL FOAMING COMPOSITIONS CONTAINING CATIONIC ACTIVE INGREDIENTS - The antimicrobial foaming composition of the present invention comprises a cationic active ingredient, a cationic compatible surfactant, a foam booster, a foam structure enhancing agent, dermal adjuvants, and a carrier. The present antimicrobial compositions are free of the antimicrobial agents triclosan (i.e., 2,4,4′-trichloro-2′hydroxy-diphenylether) and lower alcohols. They are also free of anionic surfactants. The foaming compositions have rapid cidal activity, provide stable, copious foam, and exhibit enhanced tissue (e.g. skin) compatibility. | 02-04-2016 |
20160058004 | Potentiated Biocidal Compositions and Methods of Use - The present technology relates to biocidal compositions and methods that contain and utilize at least one biocidal agent and at least one potentiator system wherein the resultant combination has an enhanced biocidal efficacy. The present technology also discloses a rapid screening assay for determining biocidal compositions with enhanced efficacy, e.g., a microbial contact kill time of 5 minutes or less. Further, the present technology provides a method of determining biocidally effective concentrations of biocidal compositions comprising at least one biocidal agent and at least one potentiator system. | 03-03-2016 |
20160136115 | T TYPE CALCIUM CHANNEL INHIBITORS - The present invention provides novel T type calcium channel inhibitors of formula (I), the use thereof in the treatment of a disease or condition in a mammal associated with influx of extracellular calcium via T type calcium channels, wherein R | 05-19-2016 |
20160175266 | NMDA RECEPTOR ANTAGONIST FORMULATION WITH REDUCED NEUROTOXICITY | 06-23-2016 |
20160192648 | ANTIMICROBIAL SANITIZER COMPOSITIONS AND METHODS OF MAKING THE SAME | 07-07-2016 |
20160199322 | WOUND TREATMENT EMPLOYING ANTIMICROBIAL COMPOSITION | 07-14-2016 |